Sanifit Therapeutics, a Spain-based developer of treatments for vascular calcification disorders spun out of University of the Balearic Islands, has been bought by pharmaceutical group Vifor Pharma for €205m ($231m) upfront that could be expanded by up to €170m in clinical, regulatory and market access milestone payments. Sanifit had raised $149m as of a $62.8m series D round in mid-2019 featuring pharmaceutical firm Lundbeck vehicle Lundbeckfonden Ventures.
Forendo Pharma, a Finland-based endometriosis drug developer backed by Karolinska Development, the commercialisation…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
